Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Affect Disord ; 295: 353-365, 2021 12 01.
Article in English | MEDLINE | ID: covidwho-1373093

ABSTRACT

BACKGROUND: There is a lack of data concerning impact of COVID-19 among older adults (OA) living at long-term care (LTC) centers. This study investigated how COVID-19 has affected this population. The prevalence of and risk factors for post-traumatic stress, depression, and anxiety were investigated. METHODS: A semi-structured interview to determine the effect of COVID-19 was conducted to 200 OA at two government LTC centers. The 17-item Post-traumatic Stress Disorder Checklist, the 9-item Patient Health Questionnaire, and the 7-item Generalized Anxiety Disorder Scale were used to evaluate post-traumatic stress, depression, and anxiety, respectively. RESULTS: Most OA reported moderate or severe impact of COVID-19. The most impacted area was financial due to decreased support from outside the center. Seventy percent of OA reported no or mild psychological stress from COVID-19; however, 5.5% had post-traumatic stress, 7.0% had depression, and 12.0% had anxiety. Higher psychological stress from COVID-19 and having respiratory tract infection symptoms were independently associated with post-traumatic stress, depression, and anxiety. Receiving COVID-19 news via social media was independently associated with post-traumatic stress and depression. Having psychiatric comorbidity was independently associated with depression. CONCLUSIONS: OA living in LTC centers reported moderate or severe impact from COVID-19, especially financial, but relatively low psychological stress. Psychological stress from COVID-19, having respiratory tract infection symptoms, and receiving COVID-19 news via social media were risk factors for psychological disorders. LIMITATIONS: The data reflected the post-outbreak period. There is limitation in the generalizability of the results for other countries with different health care systems.


Subject(s)
COVID-19 , Stress Disorders, Post-Traumatic , Aged , Anxiety , Depression , Humans , Long-Term Care , Pandemics , Risk Factors , SARS-CoV-2 , Stress Disorders, Post-Traumatic/epidemiology , Stress, Psychological/epidemiology , Thailand/epidemiology
3.
J Addict Med ; 14(6): e287-e289, 2020 12.
Article in English | MEDLINE | ID: covidwho-1020285

ABSTRACT

: Globally, there are concerns about access to healthcare and harm reduction services for people who use drugs (PWUD) during the coronavirus disease 2019 (COVID-19) pandemic. Members from the Network of Early Career Professionals working in Addiction Medicine shared their experiences of providing treatment to PWUD during the COVID-19 pandemic. Drawing on these qualitative reports, we highlight the similarities and discrepancies in access to services for PWUD in 16 countries under COVID-10 restrictions. In most countries reported here, efforts have been made to ensure continued access to services, such as mobilising opioid agonist maintenance treatment and other essential medicines to patients. However, due to travel restrictions and limited telemedicine services, several Network of Early Career Professionals working in Addiction Medicine members from lower-resourced countries experienced challenges with providing care to their patients during periods of COVID-19 lock-down. The insights provided in this commentary illustrate how the COVID-19 lock-down restrictions have impacted access to services for PWUD.


Subject(s)
Coronavirus Infections/epidemiology , Health Services Accessibility , Pneumonia, Viral/epidemiology , Substance-Related Disorders/therapy , Ambulatory Care , COVID-19 , Coronavirus Infections/prevention & control , Emergency Service, Hospital , Harm Reduction , Humans , Infection Control , Needle-Exchange Programs , Opiate Substitution Treatment , Opioid-Related Disorders/prevention & control , Opioid-Related Disorders/therapy , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Substance-Related Disorders/prevention & control
4.
J Addict Med ; 14(6): e284-e286, 2020 12.
Article in English | MEDLINE | ID: covidwho-759991

ABSTRACT

: Alcohol use is a major risk factor for infectious disease and reduction of harms associated with alcohol consumption are essential during times of humanitarian crises, such as the COVID-19 pandemic. As a network of early career professionals working in the area of addiction medicine, we provide our views with regards to national actions related to reducing alcohol-related harm and providing care for people with alcohol use disorder during COVID-19. We believe that COVID-19 related measures have affected alcohol consumption in the majority of countries represented in this commentary. Examples of these changes include changes in alcohol consumption patterns, increases in cases of alcohol withdrawal syndrome, disruptions in access to medical care for alcohol use disorder and increases in illegal production of alcohol. Our members urge that treatment for acute and severe conditions due to substance use should be considered as essential services in times of humanitarian crises like COVID-19.


Subject(s)
Alcohol Drinking/epidemiology , Alcoholism/epidemiology , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , COVID-19 , Coronavirus Infections/prevention & control , Coronavirus Infections/psychology , Humans , Infection Control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Pneumonia, Viral/psychology
SELECTION OF CITATIONS
SEARCH DETAIL